Sign in

CIK 0001798749

  • Emerging growth company

Jade Biosciences, Inc.

Sign in to watch
Ticker
JBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831377888
Phone
+1 781-312-3013
Business address
221 CRESCENT ST., BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aerovate Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 84 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-04-29 Klein Lawrence Otto Director Grant or award · Stock Option (Right to Buy) +23,017 23,017
2025-04-29 CAIN CHRISTOPHER W. Director Grant or award · Stock Option (Right to Buy) +23,017 23,017
2025-04-29 DOBMEIER ERIC Director Grant or award · Stock Option (Right to Buy) +23,017 23,017
2025-04-28 RA CAPITAL MANAGEMENT, L.P. 10% owner Other acquisition +1,062,326 1,287,858
2024-08-01 Dake Benjamin T SEE REMARKS Option exercise +1,507 $1.74 $3K 14,252
2024-08-01 Dake Benjamin T SEE REMARKS Option exercise · Stock Option (Right to Buy) −1,507 0
2024-07-31 Dake Benjamin T SEE REMARKS Option exercise +11,454 $1.74 $20K 12,745
2024-07-31 Dake Benjamin T SEE REMARKS Option exercise · Stock Option (Right to Buy) −906 0
2024-07-31 Dake Benjamin T SEE REMARKS Option exercise · Stock Option (Right to Buy) −10,548 1,507
2024-06-17 RA CAPITAL MANAGEMENT, L.P. Director Purchase +928,110 $1.67 $1.5M 7,893,678
2024-06-14 Eldridge George A SEE REMARKS Option exercise 10b5-1 +15,000 $2.14 $32K 20,022
2024-06-14 Eldridge George A SEE REMARKS Sale 10b5-1 −15,000 $25.03 $375K 5,022
2024-06-14 Eldridge George A SEE REMARKS Option exercise · Stock Option (Right to Buy) 10b5-1 −15,000 28,763
2024-06-14 Verwijs Marinus CHIEF TECHNICAL OFFICER Option exercise 10b5-1 +10,600 $14.59 $155K 10,600
2024-06-14 Verwijs Marinus CHIEF TECHNICAL OFFICER Sale 10b5-1 −10,600 $25.00 $265K 0
2024-06-14 Verwijs Marinus CHIEF TECHNICAL OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −10,600 68,800
2024-06-13 Gillies Hunter CHIEF MEDICAL OFFICER Option exercise 10b5-1 +6,000 $2.14 $13K 11,602
2024-06-13 Gillies Hunter CHIEF MEDICAL OFFICER Sale 10b5-1 −6,000 $24.50 $147K 5,602
2024-06-13 Gillies Hunter CHIEF MEDICAL OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −6,000 83,510
2024-06-05 RA CAPITAL MANAGEMENT, L.P. Director Grant or award · Stock Option (Right to Buy) +12,500 12,500

Page 2 of 16 · 315 trades